Patent · US Expired

Method and compositions for promoting osteogenesis

US7399466B2 · kind B2 · utility

23Cited by
5References
22Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 23, 2001
Grant dateJul 15, 2008
Priority date
Expiry dateMay 2, 2022

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/108
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The object of the present invention is to increase PHEX activity to improve the osteogenic process in a mammal where this process has been diminished due to pathology or a condition that require osteogenesis. Osteocalcin is an endogenous inhibitor of the PHEX activity. Therefore, the identification of a substance capable of potentiating PHEX activity by preventing the inhibitory action of endogenous inhibitors will improve osteogenesis. Since PHEX is generally associated with the growth plane of bone or teeth and the absence of osteocalcin is associated with increased bone mass, potentiation of PHEX activity can promote bone growth. Increased PHEX activity can also be obtained by administration of the enzyme itself.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.